VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in ...
Adjuvant chemoradiotherapy improves 10-year overall and recurrence-free survival for patients with high-risk endometrial cancer, but benefits vary by molecular class.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback